All Immunology articles – Page 5
-
NewsProtective human antibodies target West Nile and related viruses
New research defines vulnerable sites on West Nile virus that could inform vaccine development, and highlight antibody candidates with prophylactic and therapeutic potential. They may also guide interventions for a wider group of encephalitic orthoflavivirus infections.
-
NewsA two-pronged vaccine approach to prevent genital herpes
Researchers have taken a significant step toward a genital herpes vaccine that in preclinical models prevented infection. This study extends the original “prime and pull” approach by developing a new nanoparticle that effectively induces local immunity.
-
NewsNew study shows near-complete reduction of cervical cancer deaths among HPV-vaccinated adolescents in England
A new study suggests the Human Papilloma Virus (HPV) vaccine may be responsible for a near-complete protective effect against death from cervical cancer among women under 30 in England who received the vaccine between 12-18 years old.
-
NewsAI reveals unexpected source of antibiotic candidates in prion proteins
Prion and prion-like proteins may hide short peptides, named “prionins,” that can kill bacteria, suggesting proteins best known for their role in neurodegeneration may contain molecular features linked to immune defense, according to new research.
-
NewsEbola virus hides in the central nervous system, according to new research
Ebola virus can survive unnoticed in the human body for months or even years, hiding in areas with little immune surveillance like the central nervous system. Using a cerebral organoid model, researchers have gained valuable insights into the mechanisms of Ebola virus persistence.
-
NewsResearchers find a common weakness in major gut pathogens
The bacteria enterotoxigenic E. coli and Shigella together cause hundreds of millions of infections each year and are among the leading causes of diarrheal death, especially in children. A shared biological feature of these gut pathogens could lead to a vaccine that protects against both.
-
NewsA new HIV vaccine study reveals new hope—and new challenges—for aging patients
A new clinical trial demonstrates that novel vaccines can significantly boost T cells targeting and could contribute to curative approaches against HIV.
-
NewsYoung frogs “play it safe” when disease strikes
New research shows that young frogs prioritize growing quickly even when infected with a deadly pathogen, shifting energy toward immune defense only when infections become severe.
-
NewsResearcher secures nearly $4 million NIH grant to advance therapeutic vaccine to help end genital herpes
University of California, Irvine immunologist Lbachir BenMohamed has been awarded a $3.93 million National Institutes of Health grant to develop and test a novel therapeutic vaccine designed to prevent recurrent genital herpes.
-
NewsTherapeutic vaccine shows mixed efficacy in preventing head and neck cancer recurrence
Researchers explore the effectivity of new therapeutic cancer vaccine in preventing the recurence of human papillomavirus triggered cancers.
-
NewsStudy reveals how bacteria assemble their envelope
Researchers have discovered a key process for how the outer membrane of gram-negative bacteria attaches to the cell wall, advancing the understanding of how these bacteria frequently manifest resistance to antibiotics.
-
NewsSingle amino acid change may help viruses jump from bat to human
New research reports that a single amino-acid change alters how a coronavirus protein interacts with the human and bat immune systems, shifting the body’s response to infection.
-
NewsPathogens survive conditions on extraterrestrial locations
Microorganisms from our planet could survive on celestial bodies where water is present, such as Mars, reveals a study focusing on simulated space conditions. Our immune system reacts less effectively to pathogens that have undergone such a simulated space journey.
-
NewsShingles vaccine linked to lower dementia risk in older adults, study suggests
A target trial emulation of older adults entering skilled-nursing facilities found that those who received the recombinant shingles vaccine (RZV) had a lower risk of developing dementia over the following four years compared with those who were not vaccinated.
-
NewsmRNA flu vaccine offers immune protection against wide array of influenza virus strains
A new study has found that an investigational mRNA influenza vaccine helps the immune system recognize a wider range of influenza viruses than today’s standard flu shot, offering stronger and potentially longer-lasting protection. The vaccine, developed by Moderna, is currently under review by the U.S. Food and Drug Administration.
-
NewsA gut bacteria molecule may calm intestinal inflammation by turning down cellular energy
A new study suggests enterobactin, a molecule produced by gut bacteria, could offer a new pathway for treating inflammatory bowel disease.
-
NewsHow exercise fights implant infections: Muscle hormone “musclin” unveiled as a key defender
A new study reveals how the exercise-induced myokine musclin reprograms macrophage metabolism to clear dead cells and treat periprosthetic joint infections.
-
NewsGut bacteria linked to osteoporosis risk in primary hyperparathyroidism
Researchers studying primary hyperparathyroidism, a common endocrine disorder characterized by excessive secretion of parathyroid hormone, have identified Bifidobacterium longum as a potential microbial driver of bone loss through immune-mediated mechanisms.
-
NewsScientists track breakthrough single-dose vaccines for Andes hantavirus strain
Researchers report the development of new vaccines that, in animal testing, provided full protection against the deadly Andes hantavirus after a single dose. They are working to fast-track these single-dose vaccines into human clinical trials.
-
NewsAntibody clues could improve long Covid care and prognosis
Researchers have found that SARS-CoV-2 antibody patterns may help assess infection history, symptom severity, and cognitive complications in long Covid.